Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Violin Memory Inc (VMEM)’s Stock Plunged Today?

Nano-cap Violin Memory Inc (NYSE:VMEM) reported a fiscal first quarter loss of $0.16 per share on revenue of $9.7 million, beating the bottom-line estimate by one cent but missing the top line by $1.8 million. Total sales contracted 19.8% year-over-year, as product sales fell 39% to $4.16 million and service sales rose 5.3% to $5.56 million. The company ended the quarter with cash, restricted cash, and investments of less than one year in duration of $49.2 million at the end of the first quarter. Violin Memory Inc (NYSE:VMEM) has no debt. The company needs to stop the cash burn and losses to do well. Despite the small size, Violin Memory managed to capture the attention of several hedge funds, although its popularity inched down during the first quarter, according to the latest round of 13F filings.


Follow Violin Memory Inc (NYSE:VMEM)
Trade (NYSE:VMEM) Now!

According to most investors, hedge funds are perceived as slow, outdated investment vehicles of years past. While there are over 8000 funds in operation at present, Our experts choose to focus on the crème de la crème of this club, approximately 700 funds. These investment experts administer bulk of the hedge fund industry’s total asset base, and by tailing their best stock picks, Insider Monkey has discovered various investment strategies that have historically outpaced Mr. Market. Insider Monkey’s small-cap hedge fund strategy exceeded the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

Keeping this in mind, let’s take a look at the latest action encompassing Violin Memory Inc (NYSE:VMEM).

Heading into the second quarter of 2016, a total of seven of the hedge funds tracked by Insider Monkey held long positions in this stock, down by one from the fourth quarter of 2015. With the smart money’s sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were upping their holdings substantially (or already accumulated large positions).

Of the funds tracked by Insider Monkey, billionaire George Soros’ Soros Fund Management holds the largest position in Violin Memory Inc (NYSE:VMEM). Soros Fund Management has a $8.8 million position in the stock, comprising 0.2% of its 13F portfolio. On Soros Fund Management’s heels is Andalusian Capital Partners, managed by Michael Reeber, which holds a $4.2 million position; 3.7% of its 13F portfolio is allocated to the stock. Some other hedge funds and institutional investors with similar optimism contain Matthew Knauer and Mina Faltas’s Nokota Management, George Hall’s Clinton Group and Joseph A. Jolson’s Harvest Capital Strategies.

On the next page, we are going to take a look at some funds that dumped their stakes in Violin Memory heading into the second quarter. In addition, we are going to compare the company to some other stocks with a similar valuation in order to get a better sense of its popularity among hedge funds.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.